⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL304553 | 0.97 | — | — | |
| SCHEMBL30230076 | 0.94 | — | — | |
| SCHEMBL11470161 | 0.94 | — | — | |
| SCHEMBL28874017 | 0.94 | — | — | |
| Methane SCHEMBL3764799 | 0.94 | — | — | |
| SCHEMBL17652127 | 0.76 | CRBN (0.36) | — | |
| SCHEMBL3072776 | 0.72 | LMNA (0.38) | — | |
| SCHEMBL107616 | 0.71 | — | — | |
| Hydrazinecarboxamide SCHEMBL9860770 | 0.71 | TSHR (0.59) | — | |
| SCHEMBL10395026 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119954941-A | Antibody variants and uses thereof | 根马布私人有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119384293-A | Treatment and prevention of cancer using VISTA antigen binding molecules | 蜂鸟生物科技私人有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-119303213-A | Drug-coated balloon catheter for body cavities | 优敦力公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-112239496-B | Antibody variants and uses thereof | 根马布私人有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-113727750-B | Drug-coated balloon catheter for body cavities | 优敦力公司 | 2024-09-17 | — | — | CN | disclosed |
| CN-118541395-A | Treatment and prevention of cancer with HER3 antigen binding molecules | 癌症研究科技有限公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-112513093-B | Novel antibody and preparation method and application thereof | 奥美药业有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-118454075-A | Drug-coated balloon catheter for body cavities | 优敦力公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-118236560-A | Drug coated balloon catheter for non-vascular stenosis | 优敦力公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-117580869-A | Cells expressing HER3 antigen binding molecules | 蜂鸟生物科技私人有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-117545775-A | Cells expressing VISTA antigen binding molecules | 蜂鸟生物科技私人有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-116744945-A | Porous body for capturing cancer cells | 日本光电工业株式会社 | 2023-09-12 | — | — | CN | disclosed |
| CN-116376826-A | Compositions and methods for immune cell modulation in adoptive immunotherapy | 菲特治疗公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-111565716-B | Method of using dipivefrin | 因斯格尼斯疗法有限公司 | 2023-06-09 | — | — | CN | disclosed |
| CN-109843921-B | Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof | 艾欧凡斯生物治疗公司 | 2023-05-26 | — | — | CN | disclosed |
| CN-116162115-A | Toll-like receptor 4 immune agonist and application thereof, antiviral vaccine molecule and preparation method and application thereof | 华中师范大学 | 2023-05-26 | — | — | CN | disclosed |
| CN-116059347-A | Treatment and prevention of cancer using HER3 antigen binding molecules | 蜂鸟生物科技私人有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-108473959-B | Compositions and methods for immune cell modulation in adoptive immunotherapy | 菲特治疗公司 | 2023-04-21 | — | — | CN | disclosed |